Initial Testing of Aplidin by the Pediatric Preclinical Testing Program

Aplidin was tested in vitro at concentrations ranging from from 0.1 nM to 1.0 μM and in vivo at a dose of 0.6 mg/kg administered intraperitoneally on an every 4 days × 3 schedule that was repeated at day 21. In vitro, Aplidin was most active against acute lymphoblastic leukemia (ALL) cell lines. In...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Morton, Christopher L., Houghton, Peter J., Gorlick, Richard, Kolb, E. Anders, Lock, Richard, Carol, Hernan, Keir, Stephen T., Reynolds, C. Patrick, Kang, Min H., Maris, John M., Billups, Catherine, Smith, Malcolm A.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: 2009
Onderwerpen:
Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC2777698/
https://ncbi.nlm.nih.gov/pubmed/19418543
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pbc.21976
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items